Gene expression analysis reveals the dysregulation of immune and metabolic pathways in Alzheimer’s disease

Juan Chen; Chuncheng Xie; Yanhong Zhao; Zhiyan Li; Panpan Xu; Lifen Yao

doi:10.18632/oncotarget.12505

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers: Pathology:

Gene expression analysis reveals the dysregulation of immune and metabolic pathways in Alzheimer’s disease

Juan Chen, Chuncheng Xie, Yanhong Zhao, Zhiyan Li, Panpan Xu and Lifen Yao _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:72469-72474. https://doi.org/10.18632/oncotarget.12505

Metrics: PDF 1698 views | HTML 2765 views | ?

Abstract

Juan Chen1,*, Chuncheng Xie2,*, Yanhong Zhao3,*, Zhiyan Li1, Panpan Xu1 and Lifen Yao1

1 Department of Neurology, The First Affiliated Hospital, Harbin Medical University, Harbin, China

2 Department of Neurosurgery, The First Affiliated Hospital, Harbin Medical University, Harbin, China

3 Department of Internal Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, China

* These authors have contributed equally to this work

Correspondence to:

Lifen Yao, email:

Keywords: Alzheimer’s disease; pathway analysis; expression data; Pathology Section

Received: June 29, 2016 Accepted: September 28, 2016 Published: October 06, 2016

Abstract

In recent years, several pathway analyses of genome-wide association studies reported the involvement of metabolic and immune pathways in Alzheimer’s disease (AD). Until now, the exact mechanisms of these pathways in AD are still unclear. Here, we conducted a pathway analysis of a whole genome AD case-control expression dataset (n=41, 25 AD cases and 16 controls) from the human temporal cortex tissue. Using the differently expressed AD genes, we identified significant KEGG pathways related to metabolism and immune processes. Using the up- and down- regulated AD gene list, we further found up-regulated AD gene were significantly enriched in immune and metabolic pathways. We further compare the immune and metabolic KEGG pathways from the expression dataset with those from previous GWAS datasets, and found that most of these pathways are shared in both GWAS and expression datasets.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 12505

Publication Alerts

Post-Publication Promotion

Research Papers: Pathology:

Gene expression analysis reveals the dysregulation of immune and metabolic pathways in Alzheimer’s disease

Abstract